Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
BEYOND GENOMiX logo — Proprietary multi-omics platform delivering actionable insig...

BEYOND GENOMiX

Proprietary multi-omics platform delivering actionable insights for age-related disease diagnostics and therapeutics

Founded 2023 Switzerland Neuchatel, Switzerland 4 employees AI, Biotechnology +1

General Information

Company Name BEYOND GENOMiX
Founded Year 2023
Location Switzerland Neuchatel, Switzerland
Employees 4
Industries AI, Biotechnology, Health Care
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Licensing, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with BEYOND GENOMiX. To contact BEYOND GENOMiX, visit beyondgenomix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BEYOND GENOMiX compare?

A PDF of BEYOND GENOMiX and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BEYOND GENOMiX soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BEYOND GENOMiX

BEYOND GENOMiX, founded in 2023, is a promising Swiss startup in the AI, Biotechnology, and Health Care industries. Located in Switzerland, this deeptech venture is carving a niche in the burgeoning field of age-related disease diagnostics and therapeutics.

The company's compelling slogan, "Proprietary multi-omics platform delivering actionable insights for age-related disease diagnostics and therapeutics," succinctly captures its mission to revolutionize healthcare. By leveraging aging hallmarks analysis, BEYOND GENOMiX not only diagnoses age-associated diseases but also contributes to drug discovery, positioning itself as a key player in age-associated health advancements.

The last investment noted was part of a Support Program on 01 January 2024, with participation from SWISS INVESTMENT CORPORATION, underscoring investor confidence and potential for growth. As the company moves forward, investor interest is likely to be spurred by its innovative approach and strategic industry placement.

Business keywords: Proprietary Multi-Omics, Age-Related Disease Diagnostics, Therapeutics, Swiss Deeptech Start-up, Aging Hallmarks Analysis, Drug Discovery, MedTech, HealthTech, Precision Medicine, Age-Associated Diseases, Diagnostics

Services & Products

Genomics Pipeline Development
Telomere Analysis Technology
AI-powered Senescence Analysis
Multi-omics Data Generation
Machine Learning Insights
End-to-End Aging Hallmarks Analysis

Target Customers

Pharmaceutical Companies Biotechnology Researchers Healthcare Providers Diagnostics Companies Longevity Researchers

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Support Program Undisclosed 1
SWISS INVESTMENT CORPORATION
SWISS INVESTMENT CORPORATION
01 Jan 2024

BEYOND GENOMiX Alternatives & Competitors

View All Alternatives
BEYOND GENOMiX vs
Paratus Sciences
Paratus Sciences United States

Translating evolutionary insights into first-in-class medicines

Series A
19 employees
Biotechnology, Health Care
BEYOND GENOMiX vs
Verge Labs
Verge Labs United States

Better drugs, faster. For patients who can’t wait.

Series B
28 employees
Biotechnology, Health Care
BEYOND GENOMiX vs
Insilico Medicine
Insilico Medicine United States

#insilicomeds, #drugdiscovery, #ai, #oncology, #RL, #DL #aging, #longevity #biologics #LLMS #AIDD

IPO
286 employees
AI, Biotechnology
View all alternatives

FAQ About BEYOND GENOMiX

Proprietary multi-omics platform delivering actionable insights for age-related disease diagnostics and therapeutics
BEYOND GENOMiX was founded in 2023.
BEYOND GENOMiX is headquartered in Neuchatel, Switzerland.
BEYOND GENOMiX operates in AI, Biotechnology and Health Care. Its work centres on Proprietary Multi-Omics, Age-Related Disease Diagnostics, Therapeutics and Swiss Deeptech Start-up. Its customers include Pharmaceutical Companies, Biotechnology Researchers and Healthcare Providers.
BEYOND GENOMiX has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Licensing and Service Fee.
BEYOND GENOMiX has approximately 4 employees.
BEYOND GENOMiX has completed 1 funding round.
BEYOND GENOMiX offers: Genomics Pipeline Development, Telomere Analysis Technology, AI-powered Senescence Analysis, Multi-omics Data Generation, Machine Learning Insights, End-to-End Aging Hallmarks Analysis.
Top alternatives and competitors to BEYOND GENOMiX include Paratus Sciences, Verge Labs, Insilico Medicine, Fountain Therapeutics, Meta-flux. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BEYOND GENOMiX and Paratus Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BEYOND GENOMiX, https://bouncewatch.com/company/beyond-genomix-sa, updated 11 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout